Kevin Boyce
Physician Assistant · Ripley, WVNPI 1073577987
Payments from drug & device makers
Across 100 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$500
- Abbott$239
- Pfizer$235
- AbbVie$183
- Exact Sciences$90
- Novartis$60
- plus $369 from 12 others
What the payments were for
- Food & beverage$1,677100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $500 |
| Abbott | 13 | $239 |
| Pfizer | 16 | $235 |
| AbbVie | 8 | $183 |
| Exact Sciences | 5 | $90 |
| Novartis | 3 | $60 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $52 |
| Vertex | 2 | $49 |
| GSK | 3 | $47 |
| Lundbeck LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Corcept Therapeutics | 2 | $34 |
| Smith+Nephew | 1 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Bayer | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $12 |
How this compares
$1,677 in reported general payments places this provider in the 80th percentile of 833 physician assistant providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $51,808 |
| OzempicSemaglutide | 41 | $44,397 |
| JanuviaSitagliptin Phosphate | 41 | $32,635 |
| JardianceEmpagliflozin | 23 | $30,708 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $30,212 |
| FarxigaDapagliflozin Propanediol | 20 | $27,883 |
| Tresiba Flextouch U-100Insulin Degludec | 37 | $18,377 |
| RexultiBrexpiprazole | 12 | $17,795 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $9,076 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $8,256 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 135 | $5,746 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,818 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $3,324 |
| Dexlansoprazole DrDexlansoprazole | 12 | $2,260 |
| Rosuvastatin Calcium | 138 | $2,025 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $235 | $51,80854 claims |
| Novo NordiskOzempic | $500 | $44,39741 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $47 | $42,28763 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $36 | $17,79512 claims |
| AbbVieSynthroid | $183 | $1,54822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Ripley
- Amy ButtsWellsburg$258K
- Alexander EpperlySouth Charleston$21K
- Kelley WhoolerySouth Charleston$17K
- Jordan BrewerMorgantown$15K
- Tasha ElswickWinfield$14K
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Erik AndersonSouth Charleston$11K
- Catherine EnsingerParkersburg$11K
- Gregory PorterSouth Charleston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.